← Back to All Filings

Arteris VP Sells $66k in Stock via Pre-Scheduled 10b5-1 Plan

Low SignificanceNovember 5, 2025 at 7:33:16 PM EST

Arteris, Inc.

$AIP4CIK: 0001667011

Subscribe to track AIP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Arteris VP Sells $66k in Stock via Pre-Scheduled 10b5-1 Plan

Company: Arteris, Inc. (AIP) Form: 4 | Filed: 2025-11-05 Significance: Low

Insider: Alpern Paul L Title: VP and General Counsel | Relationship: Officer

Transaction: • Type: Sell (following option exercise) • Shares: 5,000 • Price: $13.162 • Value: $65,810 • Owned After: 65,960

Key Insight: This is a routine, pre-planned sale under a 10b5-1 plan. The transaction size is immaterial, representing just 0.012% of the company's shares outstanding.

Market Context: Such pre-scheduled sales are common for executive compensation and diversification and typically carry little to no new information for the market.

Comprehensive Analysis

SEC Filing Analysis: Arteris, Inc. (AIP)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The VP and General Counsel of Arteris, Inc. conducted a routine, pre-planned "exercise and sell" transaction, disposing of 5,000 shares for a total of $65,810.
  • Market Impact: Negligible, as the sale was executed under a 10b5-1 trading plan and represents an insignificant fraction of the company's market capitalization and shares outstanding.

Company Information

FieldValue
CompanyArteris, Inc.
Ticker SymbolAIP
CIK0001667011
IndustrySEMICONDUCTORS & RELATED DEVICES

Insider Information

FieldValue
NameAlpern Paul L
CIK0001888542
Title/PositionVP and General Counsel
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-03
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved5,000
Price Per Share$13.162
Total Value$65,810
Shares Owned After65,960
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$65,810
% of Market Cap0.012%
Shares Transacted5,000
% of Shares Outstanding0.012%
Post-Transaction Ownership65,960 shares (0.15% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $65,810 sale is immaterial against Arteris's market capitalization of $560 million.
  • Ownership Concentration: The insider's post-transaction ownership of 0.15% is not a controlling stake, and the sale did not meaningfully change this position.
  • Transaction Significance: The sale is insignificant, falling far below the thresholds for moderate or high significance (>0.1% of market cap or >0.1% of shares outstanding).

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was executed under a pre-disclosed 10b5-1 plan, indicating it was scheduled in advance and not based on new, non-public information. The size is too small to have a market impact.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume.
  • Sentiment Indicator: Neutral. Pre-planned sales for diversification or tax purposes do not signal a change in an insider's outlook on the company.

Additional Context

Special Circumstances

  • 10b5-1 Plan: The filing explicitly states the sale was made pursuant to a 10b5-1 trading plan adopted on June 5, 2025. This removes the speculative element from the sale, as it was automated and pre-scheduled.
Topics:#SECFiling#InsiderTrading#AIP#Arteris#Form4#InsiderSell#StockMarket#MarketAnalysis#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.